{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lake Forest",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "88823",
      "recalling_firm": "Akorn, Inc.",
      "address_1": "1925 W Field Ct Ste 300",
      "address_2": "",
      "postal_code": "60045-4862",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed Nationwide in the USA",
      "recall_number": "D-0004-2022",
      "product_description": "Betaxolol Ophthalmic Solution, USP, 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL dropper bottle, Rx only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  Carton NDC: 17478-705-10, Bottle NDC 17478-705-11",
      "product_quantity": "10,210 bottles",
      "reason_for_recall": "Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.",
      "recall_initiation_date": "20211004",
      "center_classification_date": "20211007",
      "termination_date": "20220817",
      "report_date": "20211013",
      "code_info": "Lot 0B61A, Exp 01/31/2022",
      "more_code_info": ""
    }
  ]
}